Adverse reactions not observed in clinical studies, but seen in animals at exposure levels similar to or even lower than clinical exposure levels and with possible relevance to clinical use, were as follows: pancreatic islet cell vacuolation (rat), testicular tubular degeneration (mouse, rat and monkey), lymphoid atrophy (mouse, rat and monkey), mixed cell inflammation of the colon/caecum (monkey), and pulmonary phospholipidosis (rat
Valituslautakunnan ratkaisu: Riidanalaisen päätöksen kumoaminen, väitteen hylkääminen ja hakemuksen hyväksyminenEMEA0.3 EMEA0.3